Fanconi anemia A protein participates in nucleolar homeostasis maintenance and ribosome biogenesis.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
01 2021
Historique:
received: 03 03 2020
accepted: 28 10 2020
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 16 4 2022
Statut: epublish

Résumé

Fanconi anemia (FA), the most common inherited bone marrow failure and leukemia predisposition syndrome, is generally attributed to alterations in DNA damage responses due to the loss of function of the DNA repair and replication rescue activities of the FANC pathway. Here, we report that FANCA deficiency, whose inactivation has been identified in two-thirds of FA patients, is associated with nucleolar homeostasis loss, mislocalization of key nucleolar proteins, including nucleolin (NCL) and nucleophosmin 1 (NPM1), as well as alterations in ribosome biogenesis and protein synthesis. FANCA coimmunoprecipitates with NCL and NPM1 in a FANCcore complex-independent manner and, unique among the FANCcore complex proteins, associates with ribosomal subunits, influencing the stoichiometry of the translational machineries. In conclusion, we have identified unexpected nucleolar and translational consequences specifically associated with FANCA deficiency that appears to be involved in both DNA damage and nucleolar stress responses, challenging current hypothesis on FA physiopathology.

Identifiants

pubmed: 33523834
pii: 7/1/eabb5414
doi: 10.1126/sciadv.abb5414
pmc: PMC7775781
pii:
doi:

Substances chimiques

FANCA protein, human 0
Fanconi Anemia Complementation Group A Protein 0
Nuclear Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Références

Nat Rev Mol Cell Biol. 2016 Jun;17(6):337-49
pubmed: 27145721
Dev Cell. 2013 Feb 25;24(4):411-25
pubmed: 23449473
Nat Rev Genet. 2015 Oct;16(10):583-97
pubmed: 26370899
Free Radic Biol Med. 2013 May;58:118-25
pubmed: 23376230
Biochem Cell Biol. 2016 Oct;94(5):419-432
pubmed: 27673355
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2561-2570
pubmed: 30692263
J Clin Invest. 2020 Mar 2;130(3):1377-1391
pubmed: 31877112
Nucleic Acids Res. 2017 Feb 17;45(3):e15
pubmed: 28180329
Cell Rep. 2019 Jan 15;26(3):564-572.e5
pubmed: 30650351
Cell Stem Cell. 2012 Jul 6;11(1):36-49
pubmed: 22683204
Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15779-84
pubmed: 18840688
Eur J Haematol. 2005 Aug;75(2):93-100
pubmed: 16000125
Mol Biol Cell. 2013 May;24(9):1334-42
pubmed: 23447702
Anemia. 2012;2012:425814
pubmed: 22737580
Cell Stem Cell. 2016 May 5;18(5):668-81
pubmed: 27053300
Blood. 2008 Feb 15;111(4):1913-23
pubmed: 18055871
Mol Cell. 2010 Oct 22;40(2):216-27
pubmed: 20965417
J Biol Chem. 2010 Nov 26;285(48):37436-44
pubmed: 20864535
Mol Carcinog. 2015 Dec;54(12):1686-99
pubmed: 25358651
Expert Rev Anticancer Ther. 2009 Sep;9(9):1283-94
pubmed: 19761432
Nat Protoc. 2012 Jul 26;7(8):1534-50
pubmed: 22836135
Nature. 2007 Jun 7;447(7145):730-4
pubmed: 17554310
Mol Cell Biol. 2018 Aug 28;38(18):
pubmed: 29987188
Nature. 2011 Jul 06;475(7354):53-8
pubmed: 21734703
Cell Rep. 2016 Mar 22;14(11):2519-27
pubmed: 26972008
Genes Dev. 2015 Jun 1;29(11):1151-63
pubmed: 26019174
Mol Cell. 2017 Jan 19;65(2):247-259
pubmed: 27986371
Blood. 2006 Jun 15;107(12):4583-8
pubmed: 16507776
J Vis Exp. 2014 May 17;(87):
pubmed: 24893926
J Clin Invest. 2007 May;117(5):1440-9
pubmed: 17431503
Leukemia. 2009 Oct;23(10):1731-43
pubmed: 19516275
Br J Haematol. 2019 Jul;186(2):343-347
pubmed: 30836427
Blood. 2006 Jun 1;107(11):4514-23
pubmed: 16455950
Oncogene. 2004 Jun 24;23(29):5004-13
pubmed: 15077170
Genes Dev. 2011 May 1;25(9):917-29
pubmed: 21536732
Curr Opin Genet Dev. 2015 Aug;33:32-40
pubmed: 26254775
Genet Mol Biol. 2017 Apr-Jun;40(2):398-407
pubmed: 28558075
Nat Struct Mol Biol. 2011 Nov 13;18(12):1432-4
pubmed: 22081012
Hum Mol Genet. 2002 Dec 1;11(25):3125-34
pubmed: 12444097
Nucleic Acids Res. 2017 Feb 28;45(4):1584-1595
pubmed: 28013268
Mol Cell. 2015 Nov 5;60(3):351-61
pubmed: 26593718
Blood. 2019 Jul 18;134(3):277-290
pubmed: 31151987
Nucleus. 2017 Mar 4;8(2):162-181
pubmed: 28406751
Hum Mol Genet. 2008 Mar 1;17(5):679-89
pubmed: 18029388
J Biol Chem. 2012 Feb 10;287(7):4800-7
pubmed: 22194614
Blood. 1994 Mar 1;83(5):1216-25
pubmed: 8118026
Mol Cell. 2018 Aug 16;71(4):621-628.e4
pubmed: 30057198
J Mol Biol. 2017 Oct 27;429(21):3168-3180
pubmed: 27600412
PLoS One. 2011;6(8):e23324
pubmed: 21912593
Int J Mol Sci. 2017 Jul 01;18(7):
pubmed: 28671574
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18767-72
pubmed: 23112151
Cancer Res. 2007 Jul 1;67(13):6230-7
pubmed: 17616680
Blood. 2009 Mar 5;113(10):2181-90
pubmed: 19109555
Antioxid Redox Signal. 2008 Nov;10(11):1909-21
pubmed: 18627348
N Engl J Med. 2005 Jan 20;352(3):254-66
pubmed: 15659725
Aging (Albany NY). 2018 Jun 21;10(6):1506-1522
pubmed: 29930218
DNA Repair (Amst). 2016 Aug;44:143-150
pubmed: 27283761
J Cell Biol. 2017 Dec 4;216(12):4007-4026
pubmed: 29030393
Nature. 2015 Apr 23;520(7548):549-52
pubmed: 25707806
Blood. 2014 Oct 30;124(18):2784-92
pubmed: 25237201
Nucleic Acids Res. 2015 Oct 15;43(18):8627-37
pubmed: 26350216
Nat Cell Biol. 2005 Mar;7(3):311-8
pubmed: 15723054
Cell. 2002 May 17;109(4):459-72
pubmed: 12086603
PLoS Genet. 2015 Nov 19;11(11):e1005674
pubmed: 26584049

Auteurs

Anna Gueiderikh (A)

CNRS-UMR9019, Équipe labellisée "La Ligue contre le Cancer," 94805 Villejuif, France.
Gustave Roussy Cancer Center, 94805 Villejuif, France.
Université Paris-Saclay-Paris Sud, Orsay, France.

Frédérique Maczkowiak-Chartois (F)

CNRS-UMR9019, Équipe labellisée "La Ligue contre le Cancer," 94805 Villejuif, France.
Gustave Roussy Cancer Center, 94805 Villejuif, France.
Université Paris-Saclay-Paris Sud, Orsay, France.

Guillaume Rouvet (G)

CNRS-UMR9019, Équipe labellisée "La Ligue contre le Cancer," 94805 Villejuif, France.
Gustave Roussy Cancer Center, 94805 Villejuif, France.
Université Paris-Saclay-Paris Sud, Orsay, France.

Sylvie Souquère-Besse (S)

Gustave Roussy Cancer Center, 94805 Villejuif, France.
Université Paris-Saclay-Paris Sud, Orsay, France.
CNRS-UMS3655, 94805 Villejuif, France.

Sébastien Apcher (S)

Gustave Roussy Cancer Center, 94805 Villejuif, France.
Université Paris-Saclay-Paris Sud, Orsay, France.
INSERM-UMR1015, 94805 Villejuif, France.

Jean-Jacques Diaz (JJ)

Université Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre Léon Bérard, Cancer Research Center of Lyon, 69373 Lyon cedex 08, France.

Filippo Rosselli (F)

CNRS-UMR9019, Équipe labellisée "La Ligue contre le Cancer," 94805 Villejuif, France. filippo.rosselli@gustaveroussy.fr.
Gustave Roussy Cancer Center, 94805 Villejuif, France.
Université Paris-Saclay-Paris Sud, Orsay, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH